1. Field of the Invention
This invention is related to methods and systems for gas phase sample preparation and introduction into a mass analysis unit.
2. Description of the Related Art
Tandem mass spectrometry (MS/MS) currently plays a central role in the identification and characterization of proteins. Successful mass spectrometric analysis of peptides and proteins relies on the ability to systematically dissect peptide backbone bonds (MS/MS). Conventional MS/MS methods, using collision-activated dissociation (CAD) where ion fragmentation is activated by collisions with buffer gas, fail in this regard if the peptide is too long (approximately >20) residues or contains either labile post-translational modifications or multiple basic residues. Moreover, while intact proteins can be dissociated with CAD, this process routinely produces only a few backbone cleavages making sequence identification challenging.
A different method (compared to CAD) for peptide ion dissociation referred to as electron capture dissociation (ECD) has been developed. In that work, low energy electrons are reacted with peptide cations in the magnetic field of a Fourier transform ion cyclotron resonance MS (FT-ICR-MS). The reaction results in the attachment of electrons to the protonated peptides producing peptide cations containing an additional electron. The odd electron peptide then undergoes very rapid (i.e., femtoseconds) rearrangement with subsequent dissociation. Unlike the collision-activated process, ECD does not cleave chemical modifications from the peptide, but rather induces random breakage of the peptide backbone cleavage that is indifferent to either peptide sequence or length. ECD fragmentation is not limited by the size of the peptide being analyzed. Up to now, fragmentation by ECD could only be performed in expensive (FT-ICR) mass spectrometer.
A further method of fragmentation, known as electron-transfer dissociation (ETD), has been recently introduced. In this method, ECD-like reactions are obtained using negatively charged ions (anions) as vehicles for electron delivery. Given the appropriate anion, the reaction should proceed to donate an electron to the peptide. Subsequently, the peptide would contain an extra electron, and that inclusion of an extra electron is expected to induce peptide backbone fragmentation, just as in ECD. Gas phase peptide cations and small organic anions react rapidly with easily controlled duration and timing. As in ECD, labile post-translational modifications remain intact, while peptide backbone bonds are cleaved with relatively little concern to peptide sequence, charge, or size. Unlike ECD, electron-transfer dissociation (ETD) can be performed with lower-cost bench-top mass spectrometers on a time scale that permits coupling with online chromatographic separations. ETD, however, has two analytical disadvantages compared to ECD: (1) ETD efficiency for doubly charged precursors is lower than with ECD; (2) ETD, which is less energetic, does not induce secondary fragmentation, thus rending the possibility to distinguish the isomeric Leu and Ile residues.
One alternative method for peptide ion dissociation with fragmentation patterns similar to ECD/ETD techniques has been developed. In this method, the peptide cations and anions are stored in radiofrequency (RF) ion traps and irradiated by a beam of metastable species (Ar or He) generated by glow discharged source Fast Atom Bombardment (FAB) gun. These metastable (neutral) species can donate an electron to the peptide cation inducing peptide backbone cleavage the same way as in ECD. An interaction of metastable species with negative peptide ions results in a transfer of electronic excitation and subsequent detachment of an electron from the anion inducing peptide fragmentation. Similar to ECD and ETD, the metastable-induced dissociation does not cleave chemical modifications from the peptide, but rather induces random breakage of the peptide backbone. The major advantage of metastable-induced dissociation is its simplicity. The neutral metastable species can be easily introduced through RF field to the areas where peptide ions are located. However, this method (at least in the current configurations) also encounters problems related to the fragmentation efficiency that is significantly lower than in the conventional ETD.
Background references to these techniques and others related to ion/ion and ion/molecule reactions at high pressure and atmospheric pressure photoionization are listed below, the entire contents of which are incorporated herein by reference.
1. Kaiser, R. E. et al Rapid Comm. Mass Spectrom. 1990, 4, 30);
2. Baba, T. et al Chem. 2004, 76, 4263-4266;
3. Zubarev, R. A. et al J. Am. Chem. Soc. 1998, 120, 3265-3266;
4. Syka, J. E. P. et al PNAS 2004, 101, 9528-9533;
5. Pitteri, S. J. et al. Anal. Chem. 2005, 77, 5662-5669;
6. Chrisman, P. A. et al J. Am. Soc. Mass Spectrom. 2005, 16, 1020-1030;
7. Zubarev, R. A., Principles of mass spectrometry applied to biomolecules, ed. J. Laskin and C. Lifshitz. 2007: Wiley;
8. Misharin, A. S. et al. Rapid Comm. Mass Spectrom. 2005, 19, 2163-2171;
9. Berkout, V. D., Anal. Chem. 2006, 78(9), 3055-3061;
10. Sparkman O. D. et al, US Pat. Appl. Publ. No. US 2006/0250138 A1;
11. Ogorzalek Loo, R. R. et al J. Am. Soc. Mass Spectrom. 1992, 3, 695-705;
12. Pui, D. Y. H. et al U.S. Pat. No. 5,992,244;
13. Stephenson, et al J. Mass Spectrom. 1998, 33 664-672;
14. Ebeling, D. D. et al Anal. Chem. 2000, 72, 5158-5161;
15. Ebeling, D. D. et al U.S. Pat. 6,649,907);
16. Whitehouse, G. et al. U.S. Patent Application Pub. No 2006/0255261;
17. Delobel, A. et al Anal. Chem. 2003, 75, 5961-5968;
18. Debois, D. et al J. Mass Spectrom. 2006, 41, 1554-1560); and
19. Demirev, P. A., Rapid Comm. Mass Spectrom. 2000, 14, 777.
In one embodiment of the invention, there is provided a method for fragmentation of analyte ions for mass spectroscopy. The method produces gas-phase analyte ions, produces gas-phase radical species separately from the analyte ions, and mixes the gas-phase analyte ions and the radical species at substantially atmospheric pressure conditions to produce fragment ions prior to introduction into a mass spectrometer.
In one embodiment of the invention, there is provided a system for mass spectroscopy. The system includes a gas-phase analyte ion source, a gas-phase radical species source separate from the gas-phase analyte ion source, a mixing region where the gas-phase analyte ions and the radical species are mixed at substantially atmospheric pressure to produce fragment ions of the analyte ions, a mass spectrometer having an entry where at least a portion of the fragment ions are introduced into a vacuum of the mass spectrometer, and a detector in the mass spectrometer which determines a mass to charge ratio analysis of the ions introduced into the vacuum of the mass spectrometer.
It is to be understood that both the foregoing general description of the invention and the following detailed description are exemplary, but are not restrictive of the invention.
A more complete appreciation of the invention and many of the attendant advantages thereof will be readily obtained as the same becomes better understood by reference to the following detailed description when considered in connection with the accompanying drawings, wherein:
The present invention relates to a novel method for fragmenting ions within an ion source maintained substantially at atmospheric pressure through the use of reactions in a gas phase between analyte ions and radical species. The fragmentation occurs as a result of interaction of the analyte ions with the gas-phase radical species produced separately from the analyte ions. In the specific case of peptide analyte ions, the invention promotes fragmentation along the peptide backbone and makes it possible to deduce the amino acid sequence of the sample. This invention can be used in any type of mass spectrometer including quadrupole, ion trap, Time-of-Flight, Orbitrap and Fourier Transform Ion Cyclotron Resonance instruments.
Specific radical species serve as “collisional partners” to produce ion ECD-like fragments at elevated pressures. Separate generation of analyte and radical species permits precise control and optimization of conditions of their production. While the following description references analyte ion production from peptides and proteins, but other types of biomolecules, for instance DNA, RNA, lipids, or metabolites can be used for analyte ion production. Suitable radical species for stimulating analyte ion production include but are not limited to reactive oxygen species such as singlet oxygen, hydroxyl, hydrogen peroxide and superoxide radicals, and other odd-electron species.
In one embodiment, the analyte ions can be generated by electrospay ionization (ESI), atmospheric pressure chemical ionization (APCI), atmospheric pressure matrix-assisted laser desorption ionization (AP-MALDI), direct analysis in real time (DART) ion source, desorption electrospray ionization (DESI), or APPI ionization methods from gas, liquid or solid samples with either positive or negative polarity.
In one embodiment, the radical species (either charged or neutral) can be produced separately from the analyte ions through any type of electrical discharge or photoionization processes. Mixing the analyte ions and the radical species can be optimized to enhance either the analyte ions or the radical species concentration.
In one embodiment, the analyte ions and radical species are mixed in a flow reactor located in the front of an atmospheric inlet orifice of a mass spectrometer (i.e., in a mixing region). In this embodiment, the time allowed for interaction between the analyte and radical species is dictated by geometry of the flow reactor and gas flow rate throughout the entrance orifice of the mass spectrometer used.
In one embodiment, additional activation occurs by way of supplying activation energy to the analyte ions in collisions with a background gas having an elevated temperature. The additional activation of the analyte ions can be conducted before or after the step of mixing of the analyte ions with the radical species.
It is advantageous if analyte ions of one type are separated from other ions produced in the ion source before the fragmentation occurs since this can significantly facilitate the identification of the analyte ions and their structures. In one embodiment, an additional step selects the analyte ions using, for example, gas or liquid-phase chromatography methods and ion mobility or field-asymmetric ion mobility methods, either separately or in combination.
Referring now to the drawings, wherein like reference numerals designate identical or corresponding parts throughout the several views,
In the particular embodiment shown in
Standard cartridge heaters (e.g., available from McMaster-Carr, Dayton, N.J.) can be used to vary the temperature of the flow reaction chamber 40, typically controlled in the range of 20-500° C. The temperature of the reaction chamber 40 can be measured by an inserted thermocouple and controlled by a temperature controller (e.g., Model CN9110A, Omega Engineering, Stamford, Conn.). The temperature of the gas flowing through the corona discharge can be adjusted separately using a coiled tube wrapped with band heaters (e.g., available from McMaster-Carr, Dayton, N.J.). The front-end of the reaction chamber 40 has in one embodiment a counter-current flow of “curtain” gas (typically, nitrogen at 0.2-5 l/min flow rates) to aid in desolvation of droplets generated by ESI and to sweep away unwanted neutral species from the reactor entrance aperture.
The flow reactor is seated onto the heated capillary 52 of MS instrument 50 (e.g., a MS instrument from LCQ Classic, Thermo Finnigan, San Jose, Calif.) with a ceramic holder that seals and provides a distance separation (e.g., about 0.5 mm) between the body of the reaction chamber 40 and the MS heated capillary. To improve ion transmission through the reaction chamber 40 into MS instrument 50, a variable DC voltage can be applied to the body of reaction chamber 40.
The corona discharge region 30 in
A gas flow meter not shown in
In an activation step, activation energy is supplied to the analyte ions in collisions with a background gas at an elevated temperature. The activation of the analyte ions can be conducted before or after or simultaneously with the step of mixing of the analyte ions with the radical species. The activation step can be used to decompose intermediate products formed in the interaction of the analyte ions with the radical species to enhance desired fragmentation pathways.
The electrospray ionization source 20 in
Another embodiment of the invention is shown in
Various methods can be used for controlling an on/off state of the radical source to allow switching between the mass analysis of the analyte ion and the mass analysis of the fragment ions. For example, an electronic switch can quickly energize/de-energize the source for generation of the radical species, for instance by cutting the current going through the electric discharge or UV lamp to provide the rapid switching.
Various embodiments of the invention include (as shown in
One example of this embodiment is schematically depicted in
The mass spectrometers shown in
Results are shown in
The fragmentation patterns observed (
In the negative ESI mode, the fragmentation pattern observed also contain c-type fragments specific to ECD/ETD and the y-/b-fragments specific to CAD, with the domination of y- and sometimes c-fragments.
In general, these results show that, in both positive and negative ESI modes, the fragment ion spectra demonstrate mixed ECD/ETD-type and CAD-type fragmentation patterns. The degree of the fragmentation will depend on the temperature of the flow reactor along with gas flow (usually ˜280 cc/min) and the current through corona discharge (typically 200 μA), but seems independent of the corona discharge polarity.
Analyte Processing
At 802, the gas-phase analyte ions can be produced by one or more of electrospray ionization, atmospheric pressure chemical ionization, photoionization, and atmospheric pressure matrix-assisted laser desorption ionization. For example, while
At 804, the gas-phase radical species can be generated by electrical discharge by which final or intermediate products of chemical reactions caused by the electrical discharge can be extracted as the gas-phase radical species. For example, while
At 806, the gas-phase analyte ions and the radical species can be mixed fro example in the reaction chamber 40 at pressures between 0.1 Torr and 10 Torr, or 10 Torr and 100 Torr, or between 100 Torr and 1 atmosphere, or above 1 atmosphere (for example, 1-10 atm.).
In one embodiment of the invention, additional energy can be supplied to the analyte ions. The additional energy can be supplied after a mixing with gas-phase radical species, or preceding mixing with the gas-phase radical species. The additional energy can be supplied to intermediate products formed in the interaction of the analyte ions with the radical species.
The additional energy can be supplied in the form of photoactivation. For example, a window (not shown) can be added to reaction chamber 40 to facilitate the irradiation of gas in reaction chamber 40 with laser light or UV light. The additional energy can be supplied in the form of by collisions with background gas having an elevated temperature, using for example the ring heaters shown in
In one embodiment of the invention, particular analyte ions are selected using at least one of gas-phase and liquid-phase chromatography, or are selected using at least on of ion mobility and field-asymmetric ion mobility methods. The selection occurs before mixing the selected analyte ion with the radical species, as shown by example in
In one embodiment of the invention, after mixing of the gas-phase analyte ions and the radical species at substantially atmospheric pressure conditions to produce fragment ions, mass to charge ratios of the fragment ions are measured in a mass spectrometer, such as for example by mass spectrometer 50 shown in
Numerous modifications and variations of the present invention are possible in light of the above teachings. It is, therefore, to be understood that within the scope of the accompanying claims, the invention may be practiced otherwise than as specifically described herein.
The U.S. Government has a paid-up license in this invention and the right in limited circumstances to require the patent owner to license others on reasonable terms as provided for by the terms of grant 1R43RR023224-01 awarded by the National Institute of Health.
Number | Name | Date | Kind |
---|---|---|---|
7170052 | Furutani et al. | Jan 2007 | B2 |
7397029 | Berkout et al. | Jul 2008 | B2 |
7534622 | Hunt et al. | May 2009 | B2 |
Number | Date | Country | |
---|---|---|---|
20090152458 A1 | Jun 2009 | US |